ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 103 filers reported holding ENDOCYTE INC in Q4 2015. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $135,000 | -38.1% | 29,575 | -29.7% | 0.02% | -31.8% |
| Q2 2015 | $218,000 | +11.2% | 42,075 | +34.4% | 0.02% | +10.0% |
| Q1 2015 | $196,000 | -3.9% | 31,300 | -3.7% | 0.02% | -4.8% |
| Q4 2014 | $204,000 | +1.0% | 32,500 | -2.3% | 0.02% | 0.0% |
| Q3 2014 | $202,000 | +33.8% | 33,250 | +45.5% | 0.02% | +31.2% |
| Q2 2014 | $151,000 | -97.4% | 22,850 | -90.7% | 0.02% | -97.5% |
| Q1 2014 | $5,870,000 | +144.8% | 246,550 | +9.8% | 0.63% | +163.2% |
| Q4 2013 | $2,398,000 | +44.1% | 224,550 | +79.9% | 0.24% | +32.0% |
| Q3 2013 | $1,664,000 | +24.3% | 124,850 | +22.4% | 0.18% | +16.8% |
| Q2 2013 | $1,339,000 | – | 102,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 4,300,000 | $59,340,000 | 17.76% |
| RA Capital Management | 5,649,884 | $77,968,000 | 5.06% |
| Avoro Capital Advisors LLC | 5,695,200 | $78,594,000 | 3.03% |
| Crosspoint Capital Strategies, LLC | 107,620 | $1,485,000 | 2.84% |
| Ghost Tree Capital, LLC | 500,000 | $6,900,000 | 2.03% |
| EMORY UNIVERSITY | 205,295 | $2,833,000 | 1.88% |
| Asymmetry Capital Management, L.P. | 103,159 | $1,424,000 | 1.40% |
| NEXTHERA CAPITAL LP | 596,000 | $8,225,000 | 1.27% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,324,299 | $32,075,000 | 1.13% |
| PFM Health Sciences, LP | 4,068,608 | $56,147,000 | 0.88% |